Archives

Wildfire Systems: $16 Million (Series B) Closed To Drive Demand For White Label Loyalty Platform

By Amit Chowdhry ● Oct 29, 2024

Wildfire Systems—a financial technology platform that powers loyalty and reward programs, shopping companions, and content monetization—announced that it has secured $16 million in Series B funding. The round was co-led by Intuit Ventures and Mucker Capital. In addition, new investors Cohen Circle, Samsung Next, Evolution VC, and Gaingels, along with existing investors TTV Capital, QED Investors, B Capital, DLA Piper, Moonshots Capital, and Citi Ventures, participated in the round.

Keurig Dr Pepper Buying Energy Drink Company GHOST In $1+ Billion Deal

By Amit Chowdhry ● Oct 29, 2024

Keurig Dr Pepper announced that it has entered into a definitive agreement to acquire GHOST Lifestyle LLC and GHOST Beverages LLC. Launched in 2016, GHOST is a lifestyle sports nutrition business with a portfolio anchored by GHOST Energy (a leading ready-to-drink energy brand).

Concord: $850 Million Closed For Driving Strategic Growth

By Amit Chowdhry ● Oct 29, 2024

Concord, a leading independent music company, closed a new series of $850 million in senior notes backed by a diverse catalog of music assets. This is Concord's third securitization offering, and it is cross-collateralized with the notes offered in 2022, which now makes up the largest music-backed asset-backed securitization to date (when taken together). These issuances validate Concord's ongoing effort to strategically grow and monetize its music assets and position the company as a consequential force in the music industry.

Tolerance Bio: $17.2 Million (Seed) Raised To Increase Healthspan By Manipulating Thymus Functions

By Amit Chowdhry ● Oct 29, 2024

Tolerance Bio, a biopharmaceutical company pioneering a novel approach to increasing healthspan by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance, announced the closing of its oversubscribed $17.2 million seed funding round, led by Columbus Venture Partners, with participation from Criteria Bio Ventures, Sessa Capital, BioAdvance, Ben Franklin Technology Partners and individual biotechnology investors.

Agrolend: $53 Million Raised For Transforming The Agribusiness Market For SMB Farmers In Brazil

By Amit Chowdhry ● Oct 29, 2024

Agrolend - a financial institution created to transform the agribusiness market for small and medium-sized farmers in Brazil by providing fast and easy credit - announced it raised $53 million in funding. Of that amount, Creation Investments (a leading global impact investor in emerging markets) made a $20 million investment in Agrolend that will help the company expand its credit offerings to industries, retailers, and farming co-operatives.

Filigran: Cybertech Ecosystem Company Secures $35 Million (Series B)

By Amit Chowdhry ● Oct 29, 2024

Filigran, a European cyber tech company, announced the completion of its $35 million (Series B) round of funding, led by global software investor Insight Partners and with continued support from existing investors Accel and Moonfire.

Birdseye Security Solutions: Equity Investment Raised From GreyLion Partners

By Amit Chowdhry ● Oct 29, 2024

Birdseye Security Solutions, a pioneer in the tech-enabled logistics security and supervision industry, announced a new equity investment from GreyLion Partners LP, a leading private equity firm that specializes in investing in high-growth businesses.

AbbVie To Buy Aliada Therapeutics In $1.4 Billion Deal

By Amit Chowdhry ● Oct 29, 2024

AbbVie and Aliada Therapeutics announced a definitive agreement under which AbbVie will buy Aliada, a biotechnology company advancing therapies using a novel blood-brain barrier (BBB)-crossing technology to address challenging central nervous system (CNS) diseases. And Aliada's lead investigational asset utilizing this delivery technology, ALIA-1758, is an anti-pyroglutamate amyloid beta (3pE-Aβ) antibody in development for treating Alzheimer's disease.